M. Francisco Gonzalez, M.D., P.A.

Columbia, South Carolina 29203

0 studies enrolling now · 2 studies all time

What they study most

Sickle Cell Disease, Sickle Cell Disease (SCD)

Studies at this site

• Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC) — Completed
• A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients — Completed